Jekyll and Hyde: which RA-ILD is it? Dr. David Liew reports on abstract OP0329 presented at the EULAR 2025 meeting in B

Tweet Author

Tweet Content

Jekyll and Hyde: which RA-ILD is it? Dr. David Liew reports on abstract OP0329 presented at the EULAR 2025 meeting in Barcelona, Spain. https://t.co/oH9nXaKRDz https://t.co/iUAJk2Q856

Links

Jekyll and Hyde: which RA-ILD is it? | RheumNow https://buff.ly/vKkxQZb

Frequent dosing in PsA: Less or More?

Jokes Aside: The Impact of Laughter in RA

27 June 2025

PCR: Prevalence, Cost, & Risk (6.27.2025)

Dr. Jack Cush reviews the news and journal reports from last week on RheumNow.com

PCR: Prevalence, Cost, & Risk (6.27.2025)

Prospective KORAIL study of 138 RA pts w/ ILD on chest CT -60% had UIP ILD. After F/U of 2.9 yrs, 35% had RA-ILD progres

Tweet Author

RheumNow

Tweet Content

Prospective KORAIL study of 138 RA pts w/ ILD on chest CT -60% had UIP ILD. After F/U of 2.9 yrs, 35% had RA-ILD progression. Baseline predictors of progression = UIP, ILD >10 %, DLCO %pred, CCP+, KL-6 levels, RA Dz activity. Useful to ID high-risk RA-ILD pts.

Aortic aneurysms w/ GCA. TriNetX study of 7,294 Bx-proven GCA vs 265,948 controls w/ tension HA. GCA had signif higher

Tweet Author

RheumNow

Tweet Content

Aortic aneurysms w/ GCA. TriNetX study of 7,294 Bx-proven GCA vs 265,948 controls w/ tension HA. GCA had signif higher 5-yr risk of aortic aneurysms (3.59%; aHR 1.98), including thoracic thoracoabdominal & abdominal. Carotid A stenosis also incr in GCA (aHR 1.59) https://t.co/15fwlHa0FG

26 June 2025

ARD's Impact Factor

Annals of the Rheumatic Diseases (ARD) is the official journal of EULAR –The European Alliance of Associations for Rheumatology. An international peer-reviewed publication committed to promoting the highest standards of scientific exchange and education. New Journal Impact Factors released for 2024 confirm ARD’s position as a leader in the field of rheumatology and musculoskeletal diseases (RMD), with EULAR Recommendations and original research driving the reach.

There's an App for That (and it works): the AXIA RCT Dr. Aurelie Najm reports on abstract LB0002 presented at the EULAR

Tweet Author

RheumNow

Tweet Content

There's an App for That (and it works): the AXIA RCT Dr. Aurelie Najm reports on abstract LB0002 presented at the EULAR 2025 meeting in Barcelona, Spain. https://t.co/IRZ1L7BqLW https://t.co/Av2vVheShE

Links

https://buff.ly/YWPYnAt

26 June 2025

HLA-B27 Testing in Practice

A single center study shows HLA-B27 testing is often performed by both by rheumatologists and nonrheumatologists for a wide array of reasons and often along with other serologic tests. Optimal use of HLA-B27 testing has yet to be defined.

Topics

Jekyll and Hyde: which RA-ILD is it? Dr. David Liew reports on abstract OP0329 presented at the EULAR 2025 meeting in B

Frequent dosing in PsA: Less or More?

Jokes Aside: The Impact of Laughter in RA

PCR: Prevalence, Cost, & Risk (6.27.2025)

Prospective KORAIL study of 138 RA pts w/ ILD on chest CT -60% had UIP ILD. After F/U of 2.9 yrs, 35% had RA-ILD progres

Aortic aneurysms w/ GCA. TriNetX study of 7,294 Bx-proven GCA vs 265,948 controls w/ tension HA. GCA had signif higher

There's an App for That (and it works): the AXIA RCT Dr. Aurelie Najm reports on abstract LB0002 presented at the EULAR

Do you get our email newsletter?